JAVITT JONATHAN C (Chief Executive Officer) received a stock award from NRX PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 3 awards
Filed: 6/10/2021ACC: 0000950142-21-001945
DirectorOfficer10% Owner· Chief Executive Officer
Since May 2021
+14.82M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
14.82M acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+46.33K
Price / share
—
Trade value
—
% of position
New position
5/24/2021
0.00→46.33K
Common Stock
Indirect
Shares
+13.35M
Price / share
—
Trade value
—
% of position
New position
5/24/2021
0.00→13.35M
Common Stock
Indirect
Shares
+1.42M
Price / share
—
Trade value
—
% of position
New position
5/24/2021
0.00→1.42M
Total
Net shares
+14.82M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/24/2021 | A · Award | +46.33K | — | — | New position | 0.00 | 46.33K |
| Common Stock Indirect | 5/24/2021 | A · Award | +13.35M | — | — | New position | 0.00 | 13.35M |
| Common Stock Indirect | 5/24/2021 | A · Award | +1.42M | — | — | New position | 0.00 | 1.42M |
| Total | +14.82M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported